Surrogate outcomes: experiences at the Common Drug Review

BACKGROUND: Surrogate outcomes are a significant challenge in drug evaluation for health technology assessment (HTA) agencies. The research objectives were to: identify factors associated with surrogate use and acceptability in Canada’s Common Drug Review (CDR) recommendations, and compare the CDR w...

Descripción completa

Detalles Bibliográficos
Autores principales: Rocchi, Angela, Khoudigian, Shoghag, Hopkins, Rob, Goeree, Ron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866929/
https://www.ncbi.nlm.nih.gov/pubmed/24341379
http://dx.doi.org/10.1186/1478-7547-11-31

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866929/
https://www.ncbi.nlm.nih.gov/pubmed/24341379
http://dx.doi.org/10.1186/1478-7547-11-31

Ejemplares similares